UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 1,073,530 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 324.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,404,576 shares of the real estate investment trust's stock after purchasing an additional 1,073,530 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.59% of Sabra Health Care REIT worth $26,139,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD grew its position in Sabra Health Care REIT by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,630 shares of the real estate investment trust's stock worth $1,812,000 after acquiring an additional 8,554 shares in the last quarter. Cetera Investment Advisers boosted its stake in Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust's stock worth $6,007,000 after buying an additional 103,413 shares in the last quarter. GAMMA Investing LLC grew its position in Sabra Health Care REIT by 40.0% during the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock valued at $57,000 after acquiring an additional 1,052 shares during the last quarter. Accel Wealth Management bought a new stake in shares of Sabra Health Care REIT in the 2nd quarter worth approximately $185,000. Finally, Gilman Hill Asset Management LLC boosted its stake in shares of Sabra Health Care REIT by 1.5% in the 2nd quarter. Gilman Hill Asset Management LLC now owns 621,173 shares of the real estate investment trust's stock valued at $9,566,000 after purchasing an additional 9,318 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Health Care REIT Trading Down 1.1 %

Shares of NASDAQ:SBRA traded down $0.20 on Thursday, hitting $18.23. The company had a trading volume of 610,403 shares, compared to its average volume of 2,032,834. The firm's 50-day simple moving average is $18.61 and its two-hundred day simple moving average is $16.92. The firm has a market capitalization of $4.31 billion, a price-to-earnings ratio of 44.95, a P/E/G ratio of 2.32 and a beta of 1.24. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT, Inc. has a 1 year low of $12.83 and a 1 year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The company had revenue of $178.00 million during the quarter, compared to analysts' expectations of $177.19 million. During the same quarter last year, the business earned $0.34 earnings per share. Equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.58%. Sabra Health Care REIT's dividend payout ratio (DPR) is 292.69%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on SBRA shares. Citigroup raised shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Wells Fargo & Company raised Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Truist Financial raised their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Scotiabank lifted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Finally, Mizuho reissued a "neutral" rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $19.14.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.